A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
for Systemic Lupus Erythematosus
Sites in Aurora, Denver +21 more locations
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All·Age: 18+
Code: NCT05869955·Phase 1·Recruiting·Listed May 2023